--- title: "Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors" type: "News" locale: "en" url: "https://longbridge.com/en/news/286160504.md" description: "Inovio Pharmaceuticals Inc. (INO) shares fell 1.40% to $1.41 on Tuesday, marking the second consecutive day of losses. The stock is currently 52.67% below its 52-week high of $2.98. In comparison, Johnson & Johnson (JNJ) rose 1.28%, while Pfizer Inc. (PFE) increased by 0.23%. The overall market showed mixed results, with the Dow Jones up 0.11% and NASDAQ down 0.71%. Trading volume for Inovio was 3.0 million, surpassing its 50-day average of 2.5 million." datetime: "2026-05-12T21:25:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286160504.md) - [en](https://longbridge.com/en/news/286160504.md) - [zh-HK](https://longbridge.com/zh-HK/news/286160504.md) --- # Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Inovio Pharmaceuticals Inc. (INO) shed 1.40% to $1.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the NASDAQ Composite Index falling 0.71% to 26,088.20. This was the stock's second consecutive day of losses. Inovio Pharmaceuticals Inc. closed 52.67% below its 52-week high of $2.98, which the company achieved on September 9th. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 1.28% to $224.26, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) rose 0.23% to $25.87. Trading volume (3.0 M) eclipsed its 50-day average volume of 2.5 M. Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 05-12-26 1725ET ### Related Stocks - [INO.US](https://longbridge.com/en/quote/INO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) ## Related News & Research - [](https://longbridge.com/en/news/286807703.md) - [Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safety](https://longbridge.com/en/news/286404245.md) - [INOVIO to Participate in Upcoming Scientific Conferences | INO Stock News](https://longbridge.com/en/news/285721077.md) - [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md) - [](https://longbridge.com/en/news/286273737.md)